Advancing Age And Menopause ppt
42 Questions
0 Views

Advancing Age And Menopause ppt

Created by
@BrighterDahlia

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the risk of developing breast cancer by age 60?

  • 1 in 30
  • 1 in 24 (correct)
  • 1 in 15
  • 1 in 12
  • What was one of the increased risks associated with estrogen plus progestin according to the WHI findings?

  • Increased risk of hypertension
  • Increased risk of heart attack (correct)
  • Increased risk of diabetes
  • Increased risk of epilepsy
  • Which treatment is FDA approved for treating hot flashes?

  • Fluoxetine
  • Paroxetine (correct)
  • Venlafaxine
  • Duloxetine
  • What is a common side effect of bisphosphonates?

    <p>Aggravation of esophagitis</p> Signup and view all the answers

    What long-term risk is associated with the use of bisphosphonates?

    <p>Atypical femoral fractures</p> Signup and view all the answers

    What is a recommended strategy when administering Hormone Replacement Therapy (HRT)?

    <p>Provide the lowest effective dose for symptom relief</p> Signup and view all the answers

    What is an alternative non-hormonal treatment option for hot flashes?

    <p>Microablative CO2 laser</p> Signup and view all the answers

    What dietary approach is suggested as an alternative to Hormone Replacement Therapy?

    <p>No specific dietary approach mentioned</p> Signup and view all the answers

    What is the primary reason for the cessation of menstruation during menopause?

    <p>Failure of ovarian follicular development</p> Signup and view all the answers

    Which of the following factors is associated with an earlier onset of menopause?

    <p>Cigarette smoking</p> Signup and view all the answers

    What is the median age for perimenopause onset?

    <p>47.5 years</p> Signup and view all the answers

    Which condition is least likely to lead to primary ovarian insufficiency?

    <p>Blindness</p> Signup and view all the answers

    During perimenopause, what happens to the secretion of inhibin?

    <p>It decreases</p> Signup and view all the answers

    In which demographic is the average age of menopause reported as 50-51 years?

    <p>In the USA</p> Signup and view all the answers

    Which hormone is still dominant in the ovaries during the perimenopausal phase?

    <p>Estradiol</p> Signup and view all the answers

    What is the major phenomenon contributing to follicular loss from birth to menopause?

    <p>Atresia</p> Signup and view all the answers

    What role does inhibin play in relation to FSH secretion?

    <p>Suppresses the secretion of FSH from granulosa cells</p> Signup and view all the answers

    At what age does fertility typically begin to decline in women?

    <p>Around age 35-37</p> Signup and view all the answers

    Which FSH level on day 3 of the cycle indicates diminished ovarian reserve?

    <p>FSH &gt; 11</p> Signup and view all the answers

    What effect does menopause have on circulating estrogen levels?

    <p>Decreases significantly</p> Signup and view all the answers

    What symptom is primarily associated with vasomotor flushes during menopause?

    <p>Transient increase in heart rate</p> Signup and view all the answers

    Which hormone ratio decreases as a result of menopause?

    <p>E2:E1 ratio</p> Signup and view all the answers

    What is a primary cardiovascular change observed years after menopause?

    <p>Significant increase in serum cholesterol</p> Signup and view all the answers

    What is one common genitourinary symptom of menopause?

    <p>Atrophy of vaginal epithelium</p> Signup and view all the answers

    What is the primary estrogen found in premenopausal women?

    <p>Estradiol (E2)</p> Signup and view all the answers

    Which of the following is NOT a clinical manifestation of decreased estrogen during menopause?

    <p>Increased fertility</p> Signup and view all the answers

    What characterizes a hot flash?

    <p>Rise in skin temperature followed by sweating</p> Signup and view all the answers

    What changes occur to testosterone levels post-menopause?

    <p>Increase in total testosterone</p> Signup and view all the answers

    What laboratory normal value is indicative of mid-follicular phase serum estrogen?

    <p>27-123 pg/mL</p> Signup and view all the answers

    What is the primary risk associated with unopposed estrogen exposure in premenopausal women?

    <p>Predisposition to disordered growth</p> Signup and view all the answers

    Which of the following is a common fracture site in postmenopausal women due to osteoporosis?

    <p>Femur</p> Signup and view all the answers

    What is the estimated percentage of menopausal women who will experience symptoms of vaginal atrophy?

    <p>10-40%</p> Signup and view all the answers

    Which of the following risk factors is NOT associated with increased osteoporosis risk in menopausal women?

    <p>Regular exercise</p> Signup and view all the answers

    What symptom is NOT typically alleviated by intravaginal estrogen therapy in menopausal women?

    <p>Hot flashes</p> Signup and view all the answers

    What is the recommended approach regarding hormone replacement therapy (HRT) dosages?

    <p>Give the lowest amount that works</p> Signup and view all the answers

    Which of the following is a common side effect of hormone replacement therapy?

    <p>Unexpected vaginal bleeding</p> Signup and view all the answers

    What is a potential side effect of intravaginal DHEA inserts?

    <p>Vaginal discharge</p> Signup and view all the answers

    Which hormone replacement method is suggested to have a lower risk of venous thromboembolic events?

    <p>Hormone Replacement Patches</p> Signup and view all the answers

    What physiological change increases the risk of sleep disturbances in menopausal women?

    <p>Decreased REM sleep</p> Signup and view all the answers

    What is the rationale for stopping the Women's Health Initiative study early?

    <p>Increased risk of invasive breast cancer</p> Signup and view all the answers

    What is one of the main benefits of postmenopausal estrogen supplementation on skin health?

    <p>Slowed wrinkling process</p> Signup and view all the answers

    Which of the following statements is true regarding hormone replacement therapy guidelines?

    <p>HRT should be avoided in those with a history of breast cancer.</p> Signup and view all the answers

    Study Notes

    Menopause and Reproductive Aging

    • Menopause: Permanent cessation of menstruation due to ovarian follicular failure; occurs around age 51.4 (median), range 48-55 years. Perimenopause, the transitional phase, typically lasts 4 years, beginning around age 47.5.
    • Climacteric: The physiologic period of ovarian function decline.
    • Primary Ovarian Insufficiency: Cessation of menstruation due to ovarian follicle depletion before age 40.
    • Factors Associated with Earlier Menopause: Surgical causes (30%), family history, smoking, (possible) blindness, abnormal karyotype, precocious puberty, and left-handedness.
    • Factors Associated with Later Menopause: Obesity, higher socioeconomic status.
    • Menopause in Different Populations: In many underdeveloped countries, lifespans are shorter, limiting the experience of menopause. In developed nations, most people live beyond menopause. This is due to lower birth rates and longer lifespans.
    • Types of Menopause: Physiologic, iatrogenic (surgical, radiation, chemo), autoimmune ovarian tissue destruction, and infections/tumors (rare).
    • Reproductive Aging: At birth, a woman has about 1 million follicles; only approximately 1,000 remain by menopause. Most follicular loss is due to atresia (follicle death) rather than ovulation. Atresia accelerates around age 37.

    Perimenopause

    • Ovarian Function in Perimenopause: Ovaries decrease in size; estradiol production declines, with estrone becoming more significant; follicle numbers decrease; inhibin production decreases (which normally suppresses FSH; reduced follicle response to FSH/LH leads to irregular ovulation).
    • Perimenopause Contraception: Women still need contraception.
    • Inhibin: A hormone produced in the gonads, pituitary, placenta, corpus luteum, and other organs. It inhibits FSH and LH. Follicle aging results in less inhibin production, leading to FSH and LH elevations (predictive of reduced fertility).
    • Fertility Decline: Fertility begins to decline around ages 35-37, before perimenopausal signs are evident. Natural pregnancy is still possible until menopause.
    • Day 3 FSH Testing: A method for assessing ovarian reserve. Elevated Day 3 FSH indicates reduced ovarian reserve (fewer eggs, reduced quality). Normal Day 3 FSH (<9) doesn't guarantee good ovarian reserve/quality.
    • Perimenopause Length: Typically +/- 3 years from the defined menopause. Characterized by shortening of menstrual cycles, or anovulatory/prolonged cycles in duration, and a shorter follicular phase.

    Menopause and Hormone Levels

    • Serum Hormone Levels at Menopause: Circulating estrogens, the ratio of estrogen to androgen, sex hormone-binding globulin (SHBG), peripheral aromatization of DHEA to estrone, E2: E1 ratio, circulating bioavailable testosterone all decrease.
    • Menopausal Hormone Levels (FSH, LH, Estradiol): FSH and LH levels generally increase, and estradiol levels sharply decrease. Testosterone levels decrease slightly, making it relatively more prevalent post-menopause.
    • Estrogen Level Testing: Estrogen levels widely fluctuate during reproductive years, making it unreliable for predicting fertility. Specific ranges for mid-follicular, periovulatory, and mid-luteal phases are provided, with postmenopausal levels being 0-40 pg/mL.
    • Diagnosis of Menopause: Determining menopause is primarily achieved through increased FSH levels.

    Menopause Symptoms and Manifestations

    • Menopause Affects Androgen Levels: Bioavailable 5-DHT increases leading to defeminization, hirsutism, and mild virilism.
    • Estrogen Changes During Menopause: In premenopausal women, estradiol (E2) is the primary estrogen, produced by the ovary. In postmenopausal women, estrone (E1) is primarily generated by peripheral conversion of Androstenedione.
    • Target Organs Affected by Estrogen: Cardiovascular, urogenital, bone, skin/teeth, and brain.
    • Symptoms of Estrogen Deficiency: Vasomotor instability, altered menstrual function, vaginal atrophy (dryness, discomfort, dyspareunia, bleeding), urinary tract symptoms (incontinence/pain), osteoporosis.
    • Hot Flashes: Temporary increases in skin temperature, vasodilation, blood flow, skin conductance, and heart rate followed by a drop and sweating.
    • Hot Flash Onset: 10% prior to menopause, 50% after cessation of menses.
    • Cardiovascular Changes: Increased risk of CVD (leading cause of death in US women); cholesterol increases, triglycerides and LDL increase, HDL decreases near/after menopause.
    • Genitourinary Symptoms of Menopause: Vaginal and urethral atrophy, reduced urethral closure pressure (increasing incontinence), urinary tract prolapse, urethritis and cystitis, increased urgency/frequency/dysuria/nocturia.
    • Menopause & Osteoporosis: Accelerated bone loss (1-2% per year), mainly trabecular bone initially, then cortical bone. Risk factors include low BMI, early menopause, family history, low calcium/vitamin D intake, high caffeine/alcohol/protein intake, and smoking.
    • Skin and Teeth Changes: Decreased epidermal thickness, collagen content, and slowed healing postmenopausally. Postmenopausal estrogen therapy preserves collagen and reduces skin thinning.
    • Neurologic Symptoms: Anxiety, depression, irritability, fatigue, headaches, sleep difficulties, inability to concentrate.

    Menopause Treatment

    • Hormone Replacement Therapy (HRT): Oral treatment with low-dose estrogen +/- progesterone (depending on uterine status). Methods (examples provided) include lowering doses, vaginal or transdermal routes.
    • HRT Indications: Moderate-severe vasomotor symptoms (hot flashes), vulvar/vaginal atrophy (GUSM), and osteoporosis prevention.
    • HRT Contraindications: History of breast cancer, CVD, VTE, stroke, active liver disease, unexplained bleeding, or high-risk endometrial cancer.
    • HRT Potential Side Effects: Headaches, breast pain/tenderness, vaginal bleeding, nausea, mood changes, leg cramps, rash, itching, diarrhea.
    • Hormone Replacement Patches: Available as estrogen-only and estrogen + progesterone; observational studies suggest that transdermal routes may have lower risk of VTE.
    • Bioidentical Hormone Replacement Therapy (BHRT): Uses plant-derived hormones; poses similar risks/benefits and side effects for conventional HRT. FDA does not consider it safer.
    • Intravaginal Estrogen Therapy: For urogenital symptoms (GUSM only); does not treat hot flashes. Potential side effects include abnormal bleeding, breast pain and nausea.
    • Intravaginal DHEA Insert (Intrarosa): For vaginal dryness/dyspareunia; potential side effects include discharge and abnormal Pap smear.
    • Why Concern about HRT? Women's Health Initiative (WHI) study—stopping early due to increased CVD/breast cancer risks with combined estrogen-progesterone therapy. WHI found mixed results (benefits/risks) of estrogen-only therapy.
    • Breast Cancer Risk & HRT: HRT is a weak risk factor but still needs consideration. Breast cancer risk in general increases over time.
    • Alternatives to HRT: Dietary/lifestyle changes.
    • Other Hot Flash Treatments: SSRIs and SNRIs (paroxetine approved FDA for hot flashes). Options for those who don't want or can't take HRT.
    • Non-Hormonal GUSM Treatments: Lifestyle changes, vaginal lubricants/moisturizers, microablative CO2 laser.
    • Osteoporosis Treatments: Bisphosphonates (decrease osteoclast activity); concerns about digestive irritation (take on empty stomach, with water, and remain upright).

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the essential concepts of menopause and reproductive aging, including the definition, stages, and associated factors of menopause. It also explores the impact of socioeconomic factors and geographical differences on the experience of menopause.

    More Like This

    Menopause and Andropause Quiz
    10 questions
    Reproductive Aging and Menopause Quiz
    30 questions
    Cycle Ovarien et Ménopause
    10 questions
    Perimenopause and Menopause
    16 questions

    Perimenopause and Menopause

    CostSavingNovaculite9652 avatar
    CostSavingNovaculite9652
    Use Quizgecko on...
    Browser
    Browser